Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of EvroTrans approved dividends for 3 months 2024

7/1/24 EUTR

Shareholders of EvroTrans approved dividends for 2023

7/1/24 EUTR

Shareholders of Rosneft Oil Company approved dividends for 2023

6/28/24 ROSN

Shareholders of Magnit approved dividends for 2023

6/28/24 MGNT

UAC to float additional share issue at ₽0.67 per share

6/28/24 UNAC

Shareholders of Bashneft approved dividends for 2023

6/28/24 BANE

Vyborg Shipyard reported for 3 months of 2024 by RAS

6/28/24 VSYD

Shareholders of Svetofor Group approved dividends for 2023

6/28/24 SVET

Qeepl has opened a round of investment raising

6/28/24 OTCI

Shareholders of Surgutneftegaz approved dividends for 2023

6/28/24 SNGS